首页> 美国卫生研究院文献>Disease Markers >Expression of MAGE-A12 in Oral Squamous Cell Carcinoma
【2h】

Expression of MAGE-A12 in Oral Squamous Cell Carcinoma

机译:MAGE-A12在口腔鳞癌中的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Melanoma associated-A antigens (MAGE-A) are silent in normal tissues except testis. However, they are activated in a variety of different tumors. Thus, their expression is highly specific to cancer cells. Reverse transcription-nested polymerase chain reaction (RT-nPCR) is a highly sensitive technique that has been used successfully for the detection ofMAGE genes in tissue samples. The aim of the study is to analyze the expression rate of MAGE-A12 in oral squamous cell carcinoma (OSCC) using a high sensitive RT-nPCR. Total of 57 tissue samples obtained from patients with OSCC and 20 normal oral mucosal (NOM) probes of otherwise healthy volunteers were included to this study. No expression of MAGE-A12 was observed in the non-neoplastic NOM tissues. MAGE-A12 was expressed in 49.1% of the investigated tumor samples. The correlation between malignant lesion and MAGE-A12 detection was significant (p < 0.001). It is concluded that results of this study may indicate MAGE-A12 as a useful additional diagnostic marker especially for the early detection of OSCC distinguishing neoplastic transformation and detection of occult and/or rare disseminated cancer cells. In addition, MAGE-A12 expression in OSCC may also determine a new immunotherapeutic target and might be warranted to develop vaccine for OSCC.
机译:黑色素瘤相关的A抗原(MAGE-A)在睾丸以外的正常组织中沉默。然而,它们在多种不同的肿瘤中被激活。因此,它们的表达对癌细胞是高度特异性的。逆转录嵌套聚合酶链反应(RT-nPCR)是一种高度灵敏的技术,已成功用于检测组织样品中的MAGE基因。这项研究的目的是使用高灵敏度的RT-nPCR分析MAGE-A12在口腔鳞状细胞癌(OSCC)中的表达率。从OSCC患者和其他健康志愿者的20例正常口腔粘膜(NOM)探针获得的总共57个组织样本被纳入了这项研究。在非肿瘤性NOM组织中未观察到MAGE-A12的表达。 MAGE-A12在49.1%的研究肿瘤样品中表达。恶性病变与MAGE-A12检测之间的相关性显着(p <0.001)。可以得出结论,这项研究的结果可能表明MAGE-A12作为有用的附加诊断标记,特别是对于OSCC的早期检测,可以区分肿瘤转化和隐匿性和/或稀有弥散性癌细胞的检测。另外,在OSCC中MAGE-A12的表达也可能确定新的免疫治疗靶点,可能有必要开发OSCC疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号